Edition:
United Kingdom

Orexigen Says Entered Into Exchange Agreements With Holders


Friday, 1 Dec 2017 

Dec 1 (Reuters) - Orexigen Therapeutics Inc ::OREXIGEN - ENTERED INTO EXCHANGE AGREEMENTS WITH HOLDERS OF 2.75% CONVERTIBLE EXCHANGE SENIOR NOTES DUE 2020, 2.75% CONVERTIBLE SENIOR NOTES DUE 2020.OREXIGEN THERAPEUTICS- AGREED TO ISSUE AGGREGATE OF 2.1 MILLION SHARES OF STOCK, IN EXCHANGE FOR ABOUT $6.5 MILLION IN AGGREGATE PRINCIPAL AMOUNT OF NOTES.